BeOne Medicines
ONC
#739
Rank
โ‚ฌ27.40 B
Marketcap
238,61ย โ‚ฌ
Share price
-2.63%
Change (1 day)
2.61%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2025 (TTM): โ‚ฌ0.14 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are โ‚ฌ4.97 Billion. In 2024 the company made an earning of -โ‚ฌ0.5 Billion, an increase over its 2023 earnings that were of -โ‚ฌ1.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.14 B-129.95%
2024 -โ‚ฌ0.5 Billion-52.95%
2023 -โ‚ฌ1.05 Billion-32.52%
2022 -โ‚ฌ1.56 Billion24.39%
2021 -โ‚ฌ1.25 Billion-13.21%
2020 -โ‚ฌ1.44 Billion72.69%
2019 -โ‚ฌ0.84 Billion36.01%
2018 -โ‚ฌ0.62 Billion616.83%
2017 -โ‚ฌ85.35 Million-15.24%
2016 -โ‚ฌ0.11 Billion107.91%
2015 -โ‚ฌ48.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ0.14 Billion-187.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ15.74 Million-109.94%๐Ÿ‡บ๐Ÿ‡ธ USA